Open AccessSafety outcomes in advanced non-small-cell lung cancer patients treated with first-line platinum-based regimens in the United States
Author(s) -
Lei Chen,
Jong Seok Kim,
Belén San Antonio,
Yajun Emily Zhu,
Lucy Mitchell,
William J. John
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.11.11
Subject(s) - medicine , neutropenia , carboplatin , febrile neutropenia , docetaxel , hazard ratio , nausea , regimen , anemia , oncology , lung cancer , pemetrexed , cancer , chemotherapy , cisplatin , confidence interval
We analyzed the treatment patterns and safety outcomes of the most common first-line platinum-based regimens initiated on or after non-small cell lung cancer (NSCLC) diagnosis in a real-world setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom